Cargando…
A 2021 Update on the Use of Liraglutide in the Modern Treatment of ‘Diabesity’: A Narrative Review
Obesity and type 2 diabetes mellitus have become a significant public health problem in the past decades. Their prevalence is increasing worldwide each year, greatly impacting the economic and personal aspects, mainly because they frequently coexist, where the term “diabesity” may be used. The drug...
Autores principales: | Tilinca, Mariana Cornelia, Tiuca, Robert Aurelian, Burlacu, Alexandru, Varga, Andreea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307742/ https://www.ncbi.nlm.nih.gov/pubmed/34209532 http://dx.doi.org/10.3390/medicina57070669 |
Ejemplares similares
-
Future perspectives in diabesity treatment: Semaglutide, a glucagon-like peptide 1 receptor agonist (Review)
por: Tilinca, Mariana Cornelia, et al.
Publicado: (2021) -
The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
por: Tilinca, Mariana Cornelia, et al.
Publicado: (2021) -
The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update
por: Tiucă, Robert Aurelian, et al.
Publicado: (2023) -
The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: a Literature Review
por: Tilinca, Mariana Cornelia, et al.
Publicado: (2021) -
Diabesity management worldwide
por: Rajeswaran, Chinnadorai
Publicado: (2016)